Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 742,959 | reported | 23 Jan 2023 | tx 8+216,878 |
| Nurix Therapeutics, Inc. | 683,333 | reported | 28 Jul 2020 | tx 12+6,672,548−6,672,548 |
| CONSTELLATION PHARMACEUTICALS INC | 99,155 | reported | 17 Feb 2021 | tx 11+4,746,043−51,116,347 |
| RAPT Therapeutics, Inc. | 72,261 | reported | 13 Sept 2021 | tx 14+497,048−2,090,431 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
1 purchase reported after at least 12 months of silence — most recent on 31 May 2022.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2023 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 9,900 | 5.00 USD | |
| 01 Jun 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 88,964 | 13.45 USD | |
| 31 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 2,040 | 13.47 USD | |
| 31 May 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 59,766 | 13.47 USD | first after silence |
| 01 Jun 2022 | PURCHASE | NGM BIOPHARMACEUTICALS INC | 3,036 | 13.45 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 279,710 | 0.00 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 1,166,666 | 0.00 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 72 | 0.00 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 84,307 | 0.00 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 84,307 | 0.00 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 48,652 | 0.00 USD | |
| 10 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 7,187 | 35.19 USD | |
| 10 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 7,320 | 35.19 USD | |
| 10 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 7,231 | 35.19 USD | |
| 13 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 4,803 | 35.25 USD | |
| 13 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 4,726 | 35.27 USD | |
| 13 Sept 2021 | SALE | RAPT Therapeutics, Inc. | 4,788 | 35.28 USD | |
| 10 Sept 2021 | OTHER | RAPT Therapeutics, Inc. | 279,710 | 0.00 USD | |
| 17 Feb 2021 | SALE | CONSTELLATION PHARMACEUTICALS INC | 10,000 | 36.95 USD | |
| 22 Sept 2020 | SALE | RAPT Therapeutics, Inc. | 608,000 | 30.85 USD | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 686,274 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 686,274 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 1,989,000 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 1,836,000 | — | |
| 28 Jul 2020 | CONVERSION | Nurix Therapeutics, Inc. | 600,000 | — |